Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study
Erika Hamilton, David M. O’Malley, Roisin E. O’Cearbhaill, Mihaela Cristea, Gini F. Fleming, Bilal Tariq, Abraham Fong, Dorothy French, M. Rossi, Daniel Brickman, Kathleen N. Moore
Topics & Concepts
MedicineRefractory (planetary science)Ovarian cancerOncologyPlatinumInternal medicineGynecologyCancerMetallurgyBiochemistryBiologyMaterials scienceCatalysisPeptidase Inhibition and AnalysisHER2/EGFR in Cancer ResearchCancer Immunotherapy and Biomarkers